Intellectual property rights
Global nurses coalition demands investigation against COVID-19 criminals

Nurses from 28 countries have filed a complaint in the UN alleging human rights violations by EU, UK, Norway, Switzerland, and Singapore for ‘the loss of countless lives’ in the pandemic.

Equitable access to Covid-19 diagnostics and therapeutics is key to ending the pandemic

One year has passed since the TRIPS waiver proposal was first tabled at the World Trade Organization, and rich countries persevere in opposing it. This has affected the availability of vaccines, and is having effect on access to diagnostics and therapeutics too

Feminists for a People’s Vaccine: challenging barriers to equitable access 

A newly launched campaign by the Third World Network and Development Alternatives with Women for a New Era highlights the questions of gender-based differences in access to Covid-19 vaccines, medicines, therapeutics and equipment

Vaccinations against COVID: How much progress have we made?

Almost 85% of all COVID vaccines administered till date have been in high income and upper-middle income countries. The poorest countries meanwhile have still only received 0.3% of all vaccine doses.

What’s new in COVID TRIPS waiver negotiations?

Sangeeta Shashikant from the Third World Network looks at the position of different countries, how pharmaceuticals are profiting from the crisis, and the urgent need for the negotiations to be fast tracked and concluded.

COVID-19 vaccine: Who holds intellectual property rights?

Immunologist Dr. Satyajit Rath and Newsclick’s Prabir Purkayastha talk about the recent debates on the intellectual property rights on vaccines and the possibilities of mass immunization

Bill Gates’ Stand on Intellectual Property Is Facing a Pushback

Alexander Zaitchik discuss Bill Gates’ recent comments on intellectual property rights in the context of COVID-19 vaccines, his long history as a spokesperson for Big Pharma, and the various struggles across the world for a fairer IPR regime and health for all

Explained: How Intellectual Property Rights are blocking vaccine production

What is standing in the way of expanding production and carrying out mass vaccination campaigns across the world?

How pharma companies created a bottleneck in vaccine distribution

Private pharma companies and developed nations have created a bottleneck in vaccine distribution through the use of patents and legislation

Lack of political will and IPR rules stand in the way of mass vaccination for COVID-19

A proposal made by India and South Africa in October last year to waive certain Intellectual Property Rights (IPR) of COVID vaccines has gained massive support across the world. Despite its potential to prevent millions of avoidable deaths, the US and its allies continue to block the proposal at the WTO.

Publishing giants sue those trying to make knowledge accessible for all

Three of the world’s most profitable publishing houses have filed a case in Delhi High Court against Sci-Hub and Libgen

How can countries overcome US monopoly over Remdesivir?

After making America sick again, president Donald Trump is trying to compensate for his administration’s failure by buying up the entire stock of Remdesivir from Gilead for the next three months for the US, and leaving nothing for the rest of the world.

    × To Subscribe